Takeshi Abe, head of the Japanese Ministry of Health and Welfare's AIDS task force in 1983-84, has become the first person to be charged in the HIV-contaminated blood scandal. He is accused of professional negligence.
Dr Abe is charged with responsibility for administration of an HIV-contaminated blood coagulant made by Green Cross to a hemophiliac, who then developed AIDS and died in December 1991, six and a half years after treatment. His arrest and charging follows a criminal complaint brought in March by the mother of the patient, who was treated at Teikyo University Hospital in Tokyo during April-May 1986 by a team of doctors advised by Dr Abe.
The prosecution says Dr Abe could have foreseen a high rate of certainty that continued use of untreated blood products would cause HIV infection, because he had been informed by US experts in September 1984 that 23 of his 48 patients treated with the products had become infected. Therefore, the charge says, Dr Abe was professionally obliged to stop the use of unheated products, but he neglected these obligations. He is accused of protecting Japanese blood product manufacturers by delaying MHW approval of safe, heat-treated products made overseas.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze